Linhui Wang

2.5k total citations
114 papers, 1.6k citations indexed

About

Linhui Wang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Linhui Wang has authored 114 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 33 papers in Molecular Biology and 26 papers in Oncology. Recurrent topics in Linhui Wang's work include Renal cell carcinoma treatment (27 papers), Ferroptosis and cancer prognosis (16 papers) and Bladder and Urothelial Cancer Treatments (11 papers). Linhui Wang is often cited by papers focused on Renal cell carcinoma treatment (27 papers), Ferroptosis and cancer prognosis (16 papers) and Bladder and Urothelial Cancer Treatments (11 papers). Linhui Wang collaborates with scholars based in China, United States and Italy. Linhui Wang's co-authors include Zhenjie Wu, Anbang Wang, Le Qu, Yi Bao, Xinxin Gan, Aimin Jiang, Tangliang Zhao, Bing Liu, Qiang Li and Yinghao Sun and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Linhui Wang

104 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linhui Wang China 22 677 448 439 353 235 114 1.6k
Jingbo Wu China 25 708 1.0× 435 1.0× 392 0.9× 491 1.4× 217 0.9× 83 2.0k
D. J. Argyle United Kingdom 22 415 0.6× 126 0.3× 608 1.4× 339 1.0× 199 0.8× 61 1.4k
Hailun Wang China 20 820 1.2× 215 0.5× 135 0.3× 302 0.9× 158 0.7× 54 1.5k
Akihiko Sano Japan 30 1.3k 1.9× 368 0.8× 375 0.9× 393 1.1× 217 0.9× 151 2.7k
Ian Hampson United Kingdom 25 1.2k 1.8× 309 0.7× 274 0.6× 418 1.2× 300 1.3× 58 2.8k
Phil Stephens United States 30 1.0k 1.5× 773 1.7× 842 1.9× 803 2.3× 150 0.6× 121 3.6k
Meng Ding China 25 1.0k 1.5× 531 1.2× 240 0.5× 172 0.5× 236 1.0× 76 2.1k
Chiara Napoletano Italy 29 731 1.1× 237 0.5× 233 0.5× 827 2.3× 781 3.3× 72 2.1k
Fred Lee United States 26 525 0.8× 138 0.3× 837 1.9× 180 0.5× 141 0.6× 66 2.1k
Tatiana P. Ugarova United States 35 861 1.3× 318 0.7× 826 1.9× 146 0.4× 702 3.0× 79 3.4k

Countries citing papers authored by Linhui Wang

Since Specialization
Citations

This map shows the geographic impact of Linhui Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linhui Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linhui Wang more than expected).

Fields of papers citing papers by Linhui Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linhui Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linhui Wang. The network helps show where Linhui Wang may publish in the future.

Co-authorship network of co-authors of Linhui Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Linhui Wang. A scholar is included among the top collaborators of Linhui Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linhui Wang. Linhui Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Aimin, et al.. (2026). Progress in RNA‐Targeted Therapeutics for Human Diseases. MedComm. 7(2). e70607–e70607.
2.
Jiang, Aimin, Wenqiang Liu, Qiwei Yang, et al.. (2024). TDERS, an exosome RNA-derived signature predicts prognosis and immunotherapeutic response in clear cell renal cell cancer: a multicohort study. SHILAP Revista de lepidopterología. 4(4). 382–394. 3 indexed citations
3.
Wang, Linhui, et al.. (2024). Systemic lupus erythematosus-related brain abnormalities in the default mode network and the limbic system: A resting-state fMRI meta-analysis. Journal of Affective Disorders. 355. 190–199. 5 indexed citations
4.
Jiang, Aimin, Jinxin Li, Ying Liu, et al.. (2024). Renal cancer: signaling pathways and advances in targeted therapies. SHILAP Revista de lepidopterología. 5(8). e676–e676. 9 indexed citations
5.
6.
Qi, Lin, Bicheng Ye, Anbang Wang, et al.. (2024). MOICS, a novel classier deciphering immune heterogeneity and aid precise management of clear cell renal cell carcinoma at multiomics level. Cancer Biology & Therapy. 25(1). 2345977–2345977.
7.
Jiang, Aimin, Yu Fang, Le Qu, et al.. (2024). SPCS, a Novel Classifier System Based on Senescence Axis Regulators Reveals Tumor Microenvironment Heterogeneity and Guides Frontline Therapy for Clear Cell Renal Carcinoma. Clinical Genitourinary Cancer. 22(2). 497–513. 6 indexed citations
8.
Li, Xiaoyong, Jiamei Yang, Geng Tian, et al.. (2024). Spatial Transcriptome and Single Nucleus Transcriptome Sequencing Reveals Tetrahydroxy Stilbene Glucoside Promotes Ovarian Organoids Development Through the Vegfa‐Ephb2 Pair. Advanced Science. 12(4). e2410098–e2410098. 3 indexed citations
9.
Jiang, Aimin, Zi‐jun Xu, Xiao Fang, et al.. (2023). RNA modification pattern‐based subtypes reveal heterogenous clinical outcomes and tumor immunity of clear cell renal cell carcinoma. SHILAP Revista de lepidopterología. 2(1). 7 indexed citations
10.
Wang, Zheng, Yunyun Wang, Jiachao Xiong, et al.. (2023). Causal effects of hypertension on risk of erectile dysfunction: A two-sample Mendelian randomization study. Frontiers in Cardiovascular Medicine. 10. 1121340–1121340. 7 indexed citations
11.
Jiang, Aimin, Le Qu, Bing Liu, Anbang Wang, & Linhui Wang. (2023). Reconsidering the role of receptors for SARS‐CoV‐2 in clear cell renal cell carcinoma: Friends or foes. SHILAP Revista de lepidopterología. 2(1).
12.
Meng, Jialin, Aimin Jiang, Xiaofan Lu, et al.. (2023). Multiomics characterization and verification of clear cell renal cell carcinoma molecular subtypes to guide precise chemotherapy and immunotherapy. SHILAP Revista de lepidopterología. 2(4). e147–e147. 21 indexed citations
13.
Jiang, Aimin, Ye Zhou, Juan Lü, et al.. (2023). Copper Death Inducer, FDX1, as a Prognostic Biomarker Reshaping Tumor Immunity in Clear Cell Renal Cell Carcinoma. Cells. 12(3). 349–349. 23 indexed citations
14.
15.
Jiang, Aimin, Ye Zhou, Wenliang Gong, et al.. (2022). CCNA2 as an Immunological Biomarker Encompassing Tumor Microenvironment and Therapeutic Response in Multiple Cancer Types. Oxidative Medicine and Cellular Longevity. 2022(1). 5910575–5910575. 38 indexed citations
16.
Jiang, Aimin, Anbang Wang, Wenliang Gong, et al.. (2022). Establishment of a Prognostic Prediction and Drug Selection Model for Patients with Clear Cell Renal Cell Carcinoma by Multiomics Data Analysis. Oxidative Medicine and Cellular Longevity. 2022(1). 3617775–3617775. 14 indexed citations
17.
Wang, Linhui, et al.. (2020). One-Pot Synthesis and High Electrochemical Performance of CuS/Cu1.8S Nanocomposites as Anodes for Lithium-Ion Batteries. Materials. 13(17). 3797–3797. 21 indexed citations
18.
Wang, Anbang, Aimin Jiang, Xinxin Gan, et al.. (2020). EGFR‐AS1 Promotes Bladder Cancer Progression by Upregulating EGFR. BioMed Research International. 2020(1). 6665974–6665974. 18 indexed citations
19.
Cai, Chen, et al.. (2012). T-Cell Immunoglobulin- and Mucin-Domain-Containing Molecule 3 Gene Polymorphisms and Renal Cell Carcinoma. DNA and Cell Biology. 31(7). 1285–1289. 24 indexed citations
20.
Xu, Yongping, Xiaoyu Li, Liji Jin, et al.. (2011). Application of chicken egg yolk immunoglobulins in the control of terrestrial and aquatic animal diseases: A review. Biotechnology Advances. 29(6). 860–868. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jingbo Wu Breakdown of academic impact, for papers by D. J. Argyle Breakdown of academic impact, for papers by Hailun Wang Breakdown of academic impact, for papers by Akihiko Sano Breakdown of academic impact, for papers by Ian Hampson Breakdown of academic impact, for papers by Phil Stephens Breakdown of academic impact, for papers by Meng Ding Breakdown of academic impact, for papers by Chiara Napoletano Breakdown of academic impact, for papers by Fred Lee Breakdown of academic impact, for papers by Tatiana P. Ugarova
Rankless by CCL
2026